BeStock  

Aquestive Therapeutics AQST

US equityMarket cap rank #3651Drug Manufacturers - Specialty & Generic
$3.46 −$0.25 (-6.61%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.52 +1.73%
Open$3.62
Prev close$3.71
Day range$3.41 – $3.65
Volume3.36M
Market cap$434.88M
P/E (TTM)–
Dividend yield–

AQST Stock News

Headlines matching Aquestive Therapeutics or the AQST ticker, most recent first.

  • H.C. Wainwright Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $10Market news · 22 Sep 2026 · Direct mention
  • Lake Street Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $6Market news · 17 Sep 2026 · Direct mention
  • LifeSci Capital Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $10Market news · 17 Sep 2026 · Direct mention
  • LifeSci Capital Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Raises Target Price to $10 PositiveMarket news · 11 Aug 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Aquestive Therapeutics (AQST) and Alto Neuroscience, Inc. (ANRO)TipRanks · 26 Jun 2026 · Direct mention
  • LifeSci Capital Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $9Market news · 26 Jun 2026 · Direct mention
  • Cantor Fitzgerald Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $11Market news · 26 Jun 2026 · Direct mention
  • Oppenheimer Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $8Market news · 25 Jun 2026 · Direct mention
  • A Quick Look at Today's Ratings for Aquestive Therapeutics(AQST.US), With a Forecast Between $6 to $9Market news · 16 May 2026 · Direct mention
  • A. G. P. Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $9Market news · 15 May 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Ardent Health Partners, Inc. (ARDT)TipRanks · 15 May 2026 · Direct mention
  • Piper Sandler Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $8Market news · 15 May 2026 · Direct mention
  • Oppenheimer Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Announces Target Price $8Market news · 9 Mar 2026 · Direct mention
  • A. G. P. Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Cuts Target Price to $9 NegativeMarket news · 6 Mar 2026 · Direct mention
  • Leerink Partners Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Announces Target Price $9Market news · 6 Mar 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on AQST.

Sign in to join the discussion.

Scroll to Top